Brensocatib Impurity 40 | CAS 206430-84-4 - Request Quote
Brensocatib Impurity 40
| SZ CAT No: | SZ-B145047 |
| CAS No | 206430-84-4 |
| Mol.F. | C14H8N2O4 |
| Mol.Wt. |
268.2 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brensocatib Impurity 40 is chemically [5,5'-bibenzo[d]oxazole]-2,2'(3H,3'H)-dione. Brensocatib Impurity 40 is supplied with detailed characterization data compliant with regulatory guideline. Brensocatib Impurity 40 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brensocatib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 206430-84-4
Purchase 206430-84-4
Order 206430-84-4
Enquire 206430-84-4
price of 206430-84-4
206430-84-4 Supplier
206430-84-4 Manufacturer
206430-84-4 Exporter
buy high quality Brensocatib Impurity 40
Purchase Brensocatib Impurity 40
Brensocatib Impurity 40 suppliers
Brensocatib Impurity 40 manufacturers
Brensocatib Impurity 40 price
Order Brensocatib Impurity 40
Enquire Brensocatib Impurity 40
Brensocatib Impurity 40 cost
Brensocatib Impurity 40 Supplier
Brensocatib Impurity 40 Distributor
Brensocatib Impurity 40 for Method Validation
Brensocatib Reference Standard
Brensocatib Impurity 40 for ANDA Filing
Brensocatib Impurity 40 for Forced Degradation Studies
Brensocatib Impurity 40 Identification Standards
Brensocatib Impurity 40 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.